In the present study, we used real-time quantitative PCR to analyze the expression of these 28 genes in 45 frozen HER2+++ tumors and 6 mammary cancer cell lines that were sensitive or resistant to trastuzumab (Additional file 1). Here, ERBB2 is linked to breast cancer.